Aug 12, 2024 / 12:00PM GMT
Operator
Good day and welcome to the Adaptimmune second quarter 2024 conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Dan Od-Cohen, Investor Relations. Please go ahead.
Dan Od-Cohen - Adaptimmune Therapeutics PLC - IR
Thank you, operator. Good morning and welcome to Adaptimmune's conference call to discuss our second quarter 2024 financial results and business updates. I would ask you to review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC. Adrian Rawcliffe, our Chief Executive Officer, is here with me for the prepared portion of the call and other members of our leadership team will be available for Q&A.
With that, I'll turn the call over to Adrian Rawcliffe. Add?
Adrian Rawcliffe - Adaptimmune Therapeutics PLC - Chief
Half Year 2024 Adaptimmune Therapeutics PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot